PharmaCan IPO Indication of Interest in Canadian MMJ

Canadian medical marijuana holding and investing company PharmaCan Capital is scheduled to go public next week, highlighting investor interest in a market expected to hit C$1.3 billion (US$1.12 billion) in sales in the coming years.

The company – which has a stake in eight medical marijuana producers, including five licensed by Health Canada – will go public through a reverse takeover of a listed entity on the Toronto Stock Exchange, according to Reuters. PharmaCan owns parts of Whistler Medical Marijuana Co. and Peace Naturals Project and fully owns The Zone Produce, a licensed producer in British Columbia.

At least five other marijuana companies have gone public this year in Canada, according to Reuters. Investors are “elbowing for a position” in the industry, Daniel Pearlstein, the life sciences analyst at M Partners, a Canadian investment bank, told the news service.

“The medical marijuana industry in Canada is in a state of competitive capitalism,” he said.

American investors, however, need to beware of sinking money into Canadian marijuana companies. A Reuters report in October noted that doing so may be seen as a violation of U.S. money laundering and drug trafficking laws. A spokesman for the Drug Enforcement Administration also said the agency is “most interested in those types of activities.”

Daily News | Briefs | Canada Marijuana News | Legal & Regulatory News for Marijuana Businesses | Marijuana Stocks & Public Companies

Leave a Reply

Your email address will not be published. Required fields are marked *

Please note: Comments are moderated by our editors who do their best to approve comments ASAP. As Marijuana Business Daily is focused on business, we approve comments that are specifically relevant to industry professionals. General opinions and questions about cannabis may not be posted.